BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 31434354)

  • 1. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas.
    Hsiao YW; Chiu LT; Chen CH; Shih WL; Lu TP
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31434354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparity of Hepatocellular Carcinoma in Tumor Microenvironment-Related Genes and Infiltrating Immune Cells between Asian and Non-Asian Populations.
    Huang LH; Hsieh TM; Huang CY; Liu YW; Wu SC; Chien PC; Hsieh CH
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global microarray profiling identified
    Weng Q; Chen M; Li M; Zheng YF; Shao G; Fan W; Xu XM; Ji J
    J Med Genet; 2019 Jan; 56(1):32-38. PubMed ID: 30120213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma.
    Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X
    Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
    Kang HJ; Oh JH; Chun SM; Kim D; Ryu YM; Hwang HS; Kim SY; An J; Cho EJ; Lee H; Shim JH; Sung CO; Yu E
    J Hepatol; 2019 Jul; 71(1):91-103. PubMed ID: 30930222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
    Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
    Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis.
    Xu X; Tan Y; Qian Y; Xue W; Wang Y; Du J; Jin L; Ding W
    Medicine (Baltimore); 2019 Jan; 98(2):e13923. PubMed ID: 30633166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
    Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
    Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma.
    Lee CF; Ling ZQ; Zhao T; Lee KR
    World J Gastroenterol; 2008 Oct; 14(39):6072-7. PubMed ID: 18932288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis.
    Ding W; Xu X; Qian Y; Xue W; Wang Y; Du J; Jin L; Tan Y
    Medicine (Baltimore); 2018 Dec; 97(50):e13301. PubMed ID: 30557978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib use in hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma: A propensity score matching study.
    Lee YC; Wang JH; Chen CH; Hung CH; Lo KC; Yen YH; Kee KM; Hu TH; Lu SN; Kuo YH
    Kaohsiung J Med Sci; 2021 Oct; 37(10):894-902. PubMed ID: 34166565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.
    Spaniel C; Honda M; Selitsky SR; Yamane D; Shimakami T; Kaneko S; Lanford RE; Lemon SM
    PLoS One; 2013; 8(10):e76867. PubMed ID: 24130799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.